SMART ASO

Serial Number 97920501
732

Registration Progress

Application Filed
May 4, 2023
Under Examination
May 7, 2024
Approved for Publication
Feb 21, 2024
Published for Opposition
Mar 12, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 2 Granted
Due: Nov 07, 2025 11 days

Trademark Image

SMART ASO

Basic Information

Serial Number
97920501
Filing Date
May 4, 2023
Published for Opposition
March 12, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
732
Status Date
Oct 23, 2025
Application
Pending
Classes
005 042

Rights Holder

Fosun Pharma USA Inc.

03
Address
104 Carnegie Center Drive, Suite 204
Princeton, NJ 08540

Ownership History

Fosun Pharma USA Inc.

Original Applicant
03
Princeton, NJ

Fosun Pharma USA Inc.

Owner at Publication
03
Princeton, NJ

Legal Representation

Attorney
Perry Gattegno

USPTO Deadlines

Next Deadline
11 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
November 07, 2025
Extension Available
Until May 07, 2025

Application History

25 events
Date Code Type Description Documents
Oct 24, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 23, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 23, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 23, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 5, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 5, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 4, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 4, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 29, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 29, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 29, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 29, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 7, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 12, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 12, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 21, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 21, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 1, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 1, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 1, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 1, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Feb 1, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 30, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 2, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 8, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of central nervous system diseases, neuromuscular diseases, metabolic diseases, and diseases related to RNA processing and translation
Class 042
Biochemical research and development; Biotechnology research; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the field of RNA-targeted drugs; Research and development in the field of nucleic acids, biologics, central nervous system diseases, neuromuscular diseases, metabolic diseases, nucleic acid-based drugs and small molecule drugs; Research and development in the pharmaceutical and biotechnology fields; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"ASO"